VVP
AVNS icon

Venture Visionary Partners’s Avanos Medical AVNS Stock Holding History

Venture Visionary Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-148
Closed -$4.05K – 533
2022
Q2 		$4.05K Buy
+148
New +$4.25K ﹤0.01% 1439

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Venture Visionary Partners's AVNS Position: Q3 2022 in Review

Venture Visionary Partners sold out of Avanos Medical (AVNS) in Q3 2022, closing a stake of 148 shares — an estimated $4.05K sold.

Venture Visionary Partners first reported a position in AVNS in Q2 2022 and held it in 1 quarter. The position peaked at $4.05K in Q2 2022. 274 funds tracked by Wall St. Rank hold AVNS as of Q3 2022.

  • Venture Visionary Partners reported no remaining Avanos Medical position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 148 Avanos Medical shares in Q3 2022, an estimated $4.05K.
  • Venture Visionary Partners first reported a position in Avanos Medical in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's Avanos Medical position peaked at $4.05K in Q2 2022.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.